
Hydar Ali
· Ph.D.University of Pennsylvania · Immunology
Active 1985–2025
Academic metrics are sourced from OpenAlex and public funding records; values may differ from Google Scholar.
About
Hydar Ali, Ph.D., is a faculty member in the Biomedical Graduate Studies at the Perelman School of Medicine, University of Pennsylvania. His research focuses on utilizing pre-clinical humanized mouse models to investigate how novel G Protein Coupled Receptor (GPCR) signaling in mast cells influences neurogenic inflammation and immune-mediated disorders. His lab aims to delineate the mechanisms by which biased signaling through GPCRs, particularly MRGPRX2, contributes to innate immunity, host defense, and various inflammatory conditions such as anaphylaxis, drug hypersensitivity, neurogenic inflammation, asthma, skin inflammation, ulcerative colitis, and periodontitis. Dr. Ali's work involves developing humanized mouse models to study receptor mutations and expression modulation, advancing understanding of mast cell activation and its role in allergic and inflammatory diseases. His contributions include identifying the role of MRGPRX2 in mast cell activation, developing antagonists, and exploring its implications in diseases, with a particular emphasis on biased signaling pathways and their therapeutic potential.
Research topics
- Biology
- Cell biology
- Chemistry
- Immunology
- Biochemistry
Selected publications
Multifaceted MRGPRX2: New insight into the role of mast cells in health and disease
Journal of Allergy and Clinical Immunology · 2021-05-03 · 161 citations
reviewOpen accessSenior authorCorrespondingMast Cell-Specific MRGPRX2: a Key Modulator of Neuro-Immune Interaction in Allergic Diseases
Current Allergy and Asthma Reports · 2021-01-01 · 86 citations
reviewOpen accessSenior authorJournal of Investigative Dermatology · 2020-10-12 · 55 citations
articleOpen accessInternational Journal of Molecular Sciences · 2021-05-18 · 41 citations
articleOpen accessSenior authorCorrespondingThe neuropeptide substance P (SP) mediates neurogenic inflammation and pain and contributes to atopic dermatitis in mice through the activation of mast cells (MCs) via Mas-related G protein-coupled receptor (GPCR)-B2 (MrgprB2, human ortholog MRGPRX2). In addition to G proteins, certain MRGPRX2 agonists activate an additional signaling pathway that involves the recruitment of β-arrestins, which contributes to receptor internalization and desensitization (balanced agonists). We found that SP cause…
Frontiers in Immunology · 2022-10-06 · 40 citations
articleOpen accessSenior authorCorrespondingMas-related G protein-coupled receptor-X2 (MRGPRX2) expressed on mast cells (MCs) contributes to hypersensitivity reactions to cationic US-Food and Drug Administration (FDA) approved drugs such as the neuromuscular blocking agent, rocuronium. In addition, activation of MRGPRX2 by the neuropeptide substance P (SP) and the pro-adrenomedullin peptide (PAMP-12) is associated with a variety of cutaneous conditions such as neurogenic inflammation, pain, atopic dermatitis, urticaria, and itch. Thus, sm…
Recent grants
Roles of novel MRGPRX2/MrgprB2 signaling in mast cells on host defense and Inflammation
NIH · $3.9M · 2019–2030
NIH · $547k · 2001
NIH · $1.1M · 2006
Frequent coauthors
- 50 shared
Ralph Snyderman
Duke University
- 47 shared
Bodduluri Haribabu
University of Louisville
- 34 shared
Ricardo M. Richardson
North Carolina Central University
- 25 shared
Michael A. Beaven
National Heart Lung and Blood Institute
- 17 shared
Hariharan Subramanian
University Medical Center Hamburg-Eppendorf
- 16 shared
Saptarshi Roy
Virginia Commonwealth University
- 13 shared
Alastair J. Barr
University of Westminster
- 13 shared
Kshitij Gupta
Labs
Hydar Ali LabPI
Education
- 1986
Ph.D., Chemistry
University College London
Similar researchers at University of Pennsylvania
- Resume-aware match score
- Save to shortlist
- AI-drafted outreach
See your match with Hydar Ali
PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.
- Free to start
- No credit card
- 30-second signup
